Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of ESTRATEST in Postmenopausal Women
NCT00141557Phase 2Terminated
- Sponsor
- Solvay
- Start
- Jul 2004
- Primary completion
- Apr 2007
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of methyltestosterone in menopause (2 arms), sponsored by Solvay. Primary endpoint: Menopause Rating Scale Total Score at 12 weeks. Started Jul 2004; status: terminated.
02
Drugs
methyltestosterone
03
Conditions
menopause
Beyond the preview
Go deeper on NCT00141557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00141557.